SPRYTAJ 50&70

SPRYTAZ 50MG &70MG

Dasatinib Tablets

SPRYTAJ is a targeted therapy used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Specifically it is used to treat cases that are Philadelphia chromosome-positive (Ph+). It is taken by mouth.